Metabolomics and Its Application to Acute Lung Diseases

Area of Science:

• Systems biology
• Biomedical research
• Metabolomics

Background:

• Metabolomics analyzes small molecules (metabolites) in biological samples.
• It complements genomics and proteomics by revealing metabolic changes linked to disease.
• Provides a snapshot of an organism's metabolic state.

Purpose of the Study:

• Review metabolomics applications in acute lung diseases (pneumonia, ARDS).
• Discuss potential for monitoring environmental toxin exposure.
• Highlight role in identifying biomarkers for disease progression and precision medicine.

Main Methods:

• Analysis of small molecules using techniques like Nuclear Magnetic Resonance (NMR) and Mass Spectrometry (MS).
• Examination of biological specimens including blood, plasma, serum, and urine.
• Review of existing experimental and clinical metabolomics studies.

Main Results:

• Metabolomics shows promise for biomarker discovery in acute lung diseases.
• Potential to predict progression to severe conditions like sepsis.
• Offers detailed patient phenotyping for precision medicine.

Conclusions:

• Incremental progress has been made in applying metabolomics to acute lung diseases.
• Understanding metabolic phenotypes is crucial for validating biomarkers.
• Further research is needed to support clinical decision-making and trial design.